Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
In case you missed the launch of Bob Herman’s incredible “Out of Pocket, Out of Reach” series about the soaring costs of employer-based health insurance, he will be talking about the series during his office hours later this month. Sign up here.
Custom gene editing drugs 4 All
In the last few years, my esteemed colleague Jason Mast has written a lot about a baby boy named KJ Muldoon, who received a gene editing drug crafted by a sprawling team of scientists to fix the unique mutation that caused his life-threatening liver disease. What if that could happen for everyone?
ARPA-H, the “moonshot” agency for health research in the U.S., announced yesterday that it will spend up to $160 million to push forward custom gene editing treatments for a spate of rare diseases. Seven different teams will pursue various conditions affecting different organ systems.
